EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

The efficacy and safety of trazodone for sleep problems in depressive patients: a GRADE-assessed systematic review and meta-analysis of clinical trials

Almuthana K Hameed, Mohammed Asiri, Muzdalifa Mejbel Fedwi, Mahmood Jawad, Pallavi Prahlad, Arshdeep Singh, Ashish Singh Chauhan, Samir Sahoo, Mandeep Singh, Mundher Kadhem

Psychopharmacology · 2026-03 · 243 (3) · 457-473

DOI: 10.1007/s00213-025-06910-y ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Psychopharmacology, online erschienen am 13.10.2025. Verfasst von Almuthana K Hameed und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, College of Applied Sciences-Heet, University of Anbar, Al Anbar, Iraq. Hauptthemen laut MEDLINE: Antidepressive Agents, Second-Generation, Depression, Sleep Wake Disorders, Trazodone. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This systematic review and meta-analysis evaluated the efficacy and safety of trazodone for managing sleep disturbances in patients with depression, addressing its dual role in improving sleep quality and depressive symptoms. METHODS: Following PRISMA guidelines, a comprehensive search was conducted across PubMed, Scopus, Cochrane Library, PsycInfo, and Web of Science from inception to February 2025. Randomized controlled trials (RCTs) assessing trazodone's effects on sleep and depression in depressive patients were included. Data extraction, quality assessment using the Cochrane ROB2 tool, and meta-analysis were performed, utilizing the standardized mean difference (SMD) and odds ratios (ORs). RESULTS: Ten RCTs (1,029 participants) were included. Trazodone significantly improved sleep quality (Pittsburgh Sleep Quality Index: SMD = -0.827, 95% CI: -1.331 to -0.323, p = 0.001) and reduced depression severity (Hamilton Depression Rating Scale: SMD = -0.365, 95% CI: -0.480 to -0.249, p < 0.001). Clinical Global Impression scores showed non-significant trends favoring trazodone (SMD = -0.209, p = 0.118). Adverse effects were more frequent with trazodone, including blurred vision (OR = 17.50, 95% CI: 2.28-134.02), somnolence (OR = 7.34, 95% CI: 2.91-18.50), and sedation (OR = 6.53, 95% CI: 3.59-11.87). CONCLUSION: Trazodone demonstrates robust efficacy for improving sleep and depressive symptoms in patients with comorbid insomnia and depression. However, its benefits must be weighed against a higher risk of adverse effects, particularly somnolence and visual disturbances. Clinicians should prioritize risk stratification and consider trazodone for patients requiring rapid symptom relief while integrating non-pharmacological interventions for long-term management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antidepressive Agents, Second-GenerationDepressionSleep Wake DisordersTrazodoneHumansRandomized Controlled Trials as TopicSleep QualityTreatment Outcome

Stichwörter der Autor:innen

DepressionMeta-analysisSleep problemsSystematic reviewTrazodone

Substanzen

Antidepressive Agents, Second-GenerationTrazodone

Autor:innen und Institutionen

  • Department of Medical Physics, College of Applied Sciences-Heet, University of Anbar, Al Anbar, Iraq.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
  • Medical Laboratory Techniques Department, College of Health and Medical Technology, University of Al-Maarif, Anbar, Iraq. muzdalifamejbelfedwi@gmail.com.
  • Department of Pharmacy, Al-Zahrawi University College, Karbala, Iraq.
  • Department of Psychology, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
  • Centre for Research Impact & Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, 140401, Punjab, India.

Förderung

  • King Khalid University

Zitieren

APA

Hameed, A. K., Asiri, M., Fedwi, M. M., Jawad, M., Prahlad, P., Singh, A., Chauhan, A. S., Sahoo, S., Singh, M., & Kadhem, M. (2026). The efficacy and safety of trazodone for sleep problems in depressive patients: a GRADE-assessed systematic review and meta-analysis of clinical trials. Psychopharmacology, 243(3), 457-473. https://doi.org/10.1007/s00213-025-06910-y

Vancouver

Hameed AK, Asiri M, Fedwi MM, Jawad M, Prahlad P, Singh A, et al. The efficacy and safety of trazodone for sleep problems in depressive patients: a GRADE-assessed systematic review and meta-analysis of clinical trials. Psychopharmacology. 2026;243(3):457-473. doi:10.1007/s00213-025-06910-y

BibTeX
@article{Hameed2026,
  author = {Hameed, Almuthana K and Asiri, Mohammed and Fedwi, Muzdalifa Mejbel and Jawad, Mahmood and Prahlad, Pallavi and Singh, Arshdeep and Chauhan, Ashish Singh and Sahoo, Samir and Singh, Mandeep and Kadhem, Mundher},
  title = {The efficacy and safety of trazodone for sleep problems in depressive patients: a GRADE-assessed systematic review and meta-analysis of clinical trials},
  journal = {Psychopharmacology},
  year = {2026},
  volume = {243},
  number = {3},
  pages = {457--473},
  doi = {10.1007/s00213-025-06910-y}
}
Kostenlos starten →